Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Teewinot Life Sciences’ Patented Biosynthetic Tech Cuts Costs and Produces Clinical-Grade Cannabinoids

Company’s IP portfolio, including proprietary technology and biosynthetic methods, features seven U.S. patents and patent filings in numerous other key countries around the world Eliminating the high costs of cultivating plants, Teewinot Life Sciences Corporation delivers pure, consistent pharmaceutical-grade cannabinoids Company’s goal is to cut costs and approach cannabinoid production like a pharmaceutical company, not […]

West Corporation to acquire Nasdaq’s Public Relations Solutions and Digital Media Services

In a testament to the value of corporate communications, West Corporation recently announced that it will acquire Nasdaq’s (NASDAQ: NDAQ) Public Relations Solutions and Digital Media Services, both segments of Nasdaq’s Corporate Solutions business. Valued at $335 million, the acquisition dovetails with West Corporation’s technology-driven communication services, which include unified communications services, safety services, interactive […]

ChineseInvestors.com, Inc. (CIIX) Offering Innovative Access to Cryptocurrency

Despite China’s ban on cryptocurrency, CIIX is positioned to lead the way in cryptocurrency education and awareness for the Chinese-speaking community Demand for bitcoin continues to rise despite China’s ban on cryptocurrency Company is committed to the education and growth of cryptocurrency and providing innovative ways of making bitcoin more accessible ChineseInvestors.com, Inc. (OTCQB: CIIX) […]

Skinvisible, Inc. (SKVI), Quoin Pharmaceuticals Proposed Merger to Address Opioid Pain Management Market

A merger between Skinvisible and Quoin will enable a successful entry on the post-surgical pain management market Opioids – which typically refer to oxycodone, hydrocodone, and fentanyl – are highly addictive painkillers; nearly three in 10 Americans prescribed opioids for chronic pain will abuse them Opioids are becoming increasingly deadly to Americans; in 2016, two-thirds […]

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Developing Alternative Solutions in Health-Boosting Market

Company offers options to patients seeking immune system-boosting alternatives Novel “scorpion venom” product builds on popular Cuban cancer-fighting therapy Developing a CBD-based nose-to-brain delivery system that will provide relief across a range of indications from pain, inflammation, seizures and neurological disorders In an era when a licensed and regulated medical industry provides a secure standard […]

Riot Blockchain, Inc. (NASDAQ: RIOT) Investments Solidify Effort to Build Decentralized Tech Platforms

Company’s investments in Verady, Coinsquare and TessPay among recent work to increase security for transactions Blockchain, cannabis sectors accounted for nearly 10 percent of rising daily activity for TD Ameritrade in 4Q2017 Estimated $10 billion in cryptocurrency transacted each day Riot Blockchain, Inc. (NASDAQ: RIOT) is advancing its focus on the rising blockchain technology and […]

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Agreement with Cannabis-Infused Edibles Manufacturer

Lexaria enters agreement with Cannfections to develop an innovative range of cannabis-infused chocolates and gummies incorporating its proprietary technology, DehydraTECH™ Cannfection’s formulation and manufacturing expertise can be offered to other Lexaria licensee partners The agreement is expected to generate new cannabis-based edible products for domestic and international markets On January 25, 2018, Lexaria Bioscience Corp. […]

 

From Our Blog

American Fusion(TM) Inc. (AMFN) Targets Government and Defense Channels to Accelerate Commercialization

April 29, 2026

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies recently announced it has engaged Samuel Reid as Government Strategy and Procurement Advisor, a step aimed at aligning its technology platform with procurement frameworks across defense, energy, and international agencies (https://ibn.fm/SK4CN). Reid brings experience in multi-agency procurement systems, including work with NATO-affiliated organizations and […]

Rotate your device 90° to view site.